Breast cancer is a major type of cancer worldwide, and overexpression of human epidermal growth factor receptor 2 (HER-2), a marker for poor prognosis, is identified in 20–30% invasive breast cancers14,15. Here, ERBB2 is linked to breast carcinoma.